Efficacy and Safety of the Combination of Transarterial Chemoembolization with Camrelizumab plus Apatinib for Advanced Hepatocellular Carcinoma: A Retrospective Study of 38 Patients from a Single Center.
Jin-Xing ZhangYu-Xing ChenChun-Gao ZhouJin LiuSheng LiuHai-Bin ShiQing-Quan ZuPublished in: Canadian journal of gastroenterology & hepatology (2022)
The combination of TACE with camrelizumab plus apatinib for the treatment of patients with advanced HCC showed promising efficacy and a manageable safety profile.
Keyphrases